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Background
The A2A adenosine receptor is a prototypical G protein-
coupled receptor. It is expressed in a wide variety of cells
including as different types as neurons, platelets, cells of
the immune system and muscle. The A2A receptor has an
unusually long C-terminus (of >120 residues), which
for the most part is dispensable for coupling to Gs.T h i s
C-terminus turned out to be the docking site for other
proteins. Using a yeast-2-hybrid screen we have previously
identified proteins interacting with the C-terminus includ-
ing ARNO/cytohesin2, SAP102 and USP4.
Methods
To verify these interactions in vivo and to identify new
interacting proteins of the A2A adenosine receptor we
chose a two-step proteomics approach: we first expressed
tagged receptors in HEK293 fibroblasts using various TAP
(tandem affinity purification)-tag variants; the differently
tagged receptors were analyzed for expression, localization
and their pharmacological properties (ligand binding and
cAMP accumulation) to identify tags suitable to further
analyze the receptor’s interactome. These tagged receptors
were then used to optimize the purification and to make
the first initial screens using 2D-nano-LC-MS/MS
approach. To prove the interaction of the A2A receptor
with promising targets found in our screens, biochemical
approaches, e.g. co-immunoprecipitation and whole-cell
binding, were performed.
Results and conclusions
We could identify two tags suitable for further analysis
of the A2A adenosine receptor interactome. Pharmacolo-
gical properties of the tagged receptors were comparable
to the native receptor. However, the tags seemed to
retain the receptor to a large extent in the endoplasmic
reticulum (ER) and hence we used this system to study
the ER/folding interactome of the receptor. LC-MS/MS
analysis of the purified ER-trapped version of the recep-
tor revealed proteins putatively involved in the folding
of the receptor, such as chaperones. We are currently
generating a transgenic mouse-model expressing the
TAP-tagged version of the A2A adenosine receptor
under the control of its endogenous promotors (homo-
logous knock-in). This will allow us to examine tissue-
and development-specific interaction partners of the
A2A adenosine receptor utilizing the optimized proteo-
mics approach.
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